Day: March 18, 2021

HOUSTON, March 18, 2021 (GLOBE NEWSWIRE) — Sysco Corporation (NYSE: SYY), the leading global foodservice distribution company, announced today the addition of three new toolkits to its Foodie Solutions platform: Brunch, Protecting Your Business and Turning Your Tables. As more restaurants reopen their dining rooms, these are the latest in a series of carefully curated tools to help customers respond quickly to shifting business requirements and trends resulting from the COVID-19 pandemic.The Brunch toolkit offers innovative ideas and recipes to help make Easter and Mother’s Day a success, including popular brunch and take-out concepts, such as Bloody Mary cocktail kits and a Mother’s Day “Berry Me in Chocolate” strawberry kit. In addition, “Sea-cuterie boards” are a unique play on the charcuterie board, a trend that skyrocketed...

Niagara Falls, NY , March 18, 2021 (GLOBE NEWSWIRE) — Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased to announce that it has retained the services of Skyline Corporate Communications Group, LLC (“Skyline”) to handle its investor relations and corporate communications activities within the financial community.Skyline Corporate Communications Group, LLC, with offices in Boston and New York City, is an investor relations and corporate communications firm that provides strategic messaging and investor communications consulting services for public corporations. Skyline provides strategic assistance for companies in the financial markets and investment community by assisting them to effectively communicate their corporate message and competitive advantages.“Our recent operating activities, growth objectives, and...

–  FHD-286 Phase 1 data anticipated as early as year-end 2021–  FHD-609 IND submission on track for the second quarter 2021–  Continued advancement of broad therapeutic pipeline targeting the chromatin regulatory systemCAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) — Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today provided a corporate update in conjunction with its 10-K filing for the year ended December 31, 2020.“With IND clearance for FHD-286 in both relapsed and/or refractory AML and metastatic uveal melanoma, we are currently initiating our first two clinical studies with initial data possible by the end of 2021, a significant milestone for our...

ATLANTA, March 18, 2021 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announced today that President and CEO Rick Eiswirth will participate in the Benzinga Biotech Small Cap Conference to be held March 24-25, 2021.Mr. Eiswirth will present on March 25 at 12:00 pm ET.Investors can view Mr. Eiswirth’s general corporate presentation once they register for the conference here and can also request a 1×1 meeting with Mr. Eiswirth.About Alimera Sciences, Inc.Alimera Sciences is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting...

RAMSEY, N.J. and BOCA RATON, Fla., March 18, 2021 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it will report financial results for the fourth quarter and full year ending December 31, 2020 on Thursday, March 25, 2021 after the U.S. financial markets close. ADMA’s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other company updates.To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior to the start time and refer to conference ID 5109699. A live audio webcast of the call will be available under “Events...

‒ Achieved Primary Endpoint in EB613 Phase 2 Clinical Trial ‒‒ Final Data, Including Bone Mineral Density, Expected in Q2:21 ‒‒ FDA Approval of EB613 IND for the Treatment of Osteoporosis Enables Initial U.S. Clinical Trial ‒‒ Amgen Collaboration Continues to Progress; Company Evaluating Additional Molecules, Including GLP-2, in Multiple Pre-clinical Studies ‒‒ Company Strengthened Balance Sheet and Now Funded into the Second Quarter of 2022 ‒‒ Company to Host Conference Call and Webcast Today at 8:30 a.m. ET ‒BOSTON and JERUSALEM, March 18, 2021 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced its financial and operating results for the quarter and year ended December 31, 2020 and provided an update on its clinical programs and pre-clinical...

HIGHLANDS RANCH, Colo., March 18, 2021 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced that it plans to release financial results for the fourth quarter and full year ended December 31, 2020 after market close on Thursday, March 25, 2021. The Company will conduct a conference call the same day at 5:00 p.m. (Eastern Time) to review the results as well as provide an overview of the Company’s recent milestones and growth strategy.To access the conference call, please dial (877) 451-6152, or for international callers, (201) 389-0879. A replay will be available shortly after the call...

MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) — Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced the appointment of Jeryl “Jeri” Hilleman to its Board of Directors. Ms. Hilleman will serve as Chair of the Audit Committee.“We welcome Jeri to our Board and look forward to benefitting from her public company leadership as a chief financial officer and corporate director at multiple life science companies,” said Brian Coe, Chief Executive Officer of Talis. “Jeri’s experience and guidance will be instrumental as we continue to scale our business in preparation for the commercial launch of Talis One™.”Ms. Hilleman brings over 20 years of executive leadership and financial experience to Talis. She currently...

INDIANAPOLIS, March 18, 2021 (GLOBE NEWSWIRE) — Kite Realty Group Trust (NYSE: KRG) (the “Company”) announced today that on March 17, 2021 its operating partnership, Kite Realty Group, L.P. (the “Operating Partnership”), priced an offering of $175 million aggregate principal amount of 0.75% exchangeable senior notes due 2027 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Operating Partnership also granted the initial purchasers of the notes an option to purchase up to an additional $25 million aggregate principal amount of notes. The sale of the notes is expected to close on March 22, 2021, subject to customary closing conditions.The notes will be the Operating Partnership’s senior unsecured...

OTTAWA, March 18, 2021 (GLOBE NEWSWIRE) — Cornerstone Capital Resources Inc. (“Cornerstone” or “the Company”) (TSXV-CGP) (F-GWN) (B-GWN) (OTC-CTNXF) is pleased to provide an update on its Bramaderos gold and copper joint venture in southern Ecuador (see Figure 1) in which it has a 12.5% interest carried by JV partner and project operator Sunstone Metals Inc. (ASX: STM) through to the start of commercial production (see “About Bramaderos”, below).Figures related to this news release can be seen in PDF format by accessing the version of this release on the Company’s website (www.cornerstoneresources.com) or by clicking on the link below:https://cornerstoneresources.com/site/assets/files/5805/nr21-07figures.pdf.HIGHLIGHTS:Visual inspection reveals copper as chalcopyrite1is present in the first hole (BMDD008) at the Brama porphyry targetThe...